Zelira Therapeutics Limited (ASX:ZLD)
Australia · Delayed Price · Currency is AUD 0.6500
0.00 (0.00%)
Jan 30, 2026, 3:58 PM AEST
Zelira Therapeutics Market Cap
Zelira Therapeutics has a market cap or net worth of 7.73 million as of January 30, 2026. Its market cap has increased by 13.58% in one year.
Market Cap
7.73M
Enterprise Value
10.04M
Revenue
656.00
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since November 22, 2016, Zelira Therapeutics's market cap has decreased from 15.39M to 7.73M, a decrease of -49.75%. That is a compound annual growth rate of -7.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 7.73M | 52.94% |
| Dec 30, 2025 | 5.06M | -28.13% |
| Dec 31, 2024 | 7.04M | -31.11% |
| Dec 29, 2023 | 10.21M | 6.63% |
| Dec 30, 2022 | 9.58M | -77.35% |
| Dec 31, 2021 | 42.28M | -61.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AdAlta | 11.48M |
| Immuron | 11.39M |
| Patrys | 11.24M |
| Chimeric Therapeutics | 11.05M |
| Bio-Gene Technology | 9.46M |
| Invex Therapeutics | 9.02M |
| Vectus Biosystems | 7.48M |
| Biotron | 7.23M |